Navigation Links
Soon, a Vaccine That Could Keep All Types of Flu Away for Lifetime

British scientists are developing a flu vaccine that will give lifelong benefit to patients and it is also expected to fight anything from winter flu to bird flu .

Compared to traditional jabs, the new FLU-v vaccine is easier to make and can also be stocked for a global epidemic. "We expect one course of injections - probably of two a week apart - to give life-long immunity," the Daily Mail quoted Dr Stuart Robinson of the Buckinghamshire company PepTcell, which developed the vaccine, as saying.

The new vaccine is based on proteins that are common to all strains of the virus, which have not altered for about 60 years. The new vaccine makes immune system cells cytotoxic T cells to fight the virus, rather in bringing in antibodies.

Lab tests have shown that FLUv can save mice, for more than half the treated mice survived, while unvaccinated creatures died. "We are in real need of new types of vaccine. Anything that gives a more rapid response would be of great interest," Professor Hugh Pennington, emeritus professor at Aberdeen University, said.

Professor Malcolm McCrae of Warwick University said the vaccine could be a useful short-term measure against a totally new strain.

It is expected that human trials of FLU-v will start in 2008 and if they prove to be effective, it could be on the market in three to five years.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
(Date:4/25/2017)... ... 2017 , ... Amendia, Inc., designer, developer, and manufacturer of ... and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization dedicated to ... spine deformity cases, particularly in children. , GSO’s focus is to provide hands-on ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with ... — the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , ... to improve the lives of the poor and underserved in other parts of the ...
(Date:4/24/2017)... ... , ... As part of the nationwide Days of Remembrance effort led by ... and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that ... to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: